PDCD1 and myeloid sarcoma: Although the regulatory mechanisms of the PD-1/PD-L1 axis during MS onset and progression remain unclear, it has been gradually established that the PD-1/PD-L1 axis is a classical immune suppressor in MS (Javan et al., 2016).